To investigate the correlation of dysregulated hnRNPA2B1 expression with GC progression, we analyzed hnRNPA2B1 expression levels with the clinical characteristics of GC patients in this cohort (Fig. 2b). Here, HNRNPA2B1 is linked to gastric cancer.